NCT07541612

Brief Summary

This prospective observational study aims to evaluate the feasibility and clinical utility of near-infrared spectroscopy (NIRS) monitoring applied to paraspinal muscles as a surrogate marker of spinal cord perfusion in patients undergoing major noncardiac surgery. Spinal cord ischemia represents a rare but devastating complication, often difficult to detect in real time. NIRS provides a non-invasive, continuous monitoring of regional tissue oxygen saturation (rSO₂), potentially reflecting microcirculatory changes in paraspinal tissues and indirectly spinal cord perfusion. The study will enroll adult patients undergoing major surgery requiring advanced hemodynamic monitoring. NIRS sensors will be placed over paraspinal regions, and rSO₂ values will be continuously recorded throughout the perioperative period. Hemodynamic parameters, including arterial pressure, cardiac output, and other relevant clinical variables, will be simultaneously collected. The primary objective is to assess changes in paraspinal rSO₂ during perioperative management and their relationship with systemic hemodynamic variables. Secondary objectives include the evaluation of the association between rSO₂ variations and postoperative neurological outcomes, as well as the feasibility and reliability of this monitoring technique in routine clinical practice. This study may provide preliminary evidence supporting the use of NIRS as a bedside, non-invasive tool for early detection of impaired spinal cord perfusion and for guiding hemodynamic optimization strategies.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Aug 2025Mar 2027

Study Start

First participant enrolled

August 23, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 21, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2027

Last Updated

April 21, 2026

Status Verified

March 1, 2026

Enrollment Period

1.4 years

First QC Date

April 14, 2026

Last Update Submit

April 14, 2026

Conditions

Keywords

Near-Infrared Spectroscopy

Outcome Measures

Primary Outcomes (1)

  • Intraoperative detection of spinal cord ischemia by paraspinal NIRS

    Incidence of intraoperative spinal cord ischemia identified by significant reduction in paraspinal regional oxygen saturation measured with near-infrared spectroscopy during thoracoabdominal aortic surgery.

    From anesthesia induction until completion of surgery

Study Arms (2)

High-risk patients (NIRS + CSF drainage)

Patients at high risk of spinal cord ischemia undergoing aortic surgery, managed with paraspinal near-infrared spectroscopy (NIRS) monitoring combined with cerebrospinal fluid (CSF) drainage according to the study protocol.

Diagnostic Test: Near-Infrared Spectroscopy (NIRS)Procedure: Cerebrospinal fluid drainage via lumbar catheter (L3-L4) to maintain cerebrospinal fluid pressure below target levels and optimize spinal cord perfusion pressure during aortic surgery.

Low-risk patients (NIRS alone)

Patients at lower risk of spinal cord ischemia undergoing aortic surgery, managed with paraspinal near-infrared spectroscopy (NIRS) monitoring without cerebrospinal fluid drainage according to the study protocol.

Diagnostic Test: Near-Infrared Spectroscopy (NIRS)

Interventions

Paraspinal sensors are applied bilaterally at thoracic-lumbar levels (approximately T8-L2) to continuously monitor regional oxygen saturation (rSO2). Data are recorded intraoperatively and during the early postoperative period (up to 72 hours), allowing detection of changes potentially associated with spinal cord hypoperfusion.

Also known as: NIRS MONITORING, REGIONAL OXIMETRY, rSO2 monitoring, Near-Infrared Spectroscopy
High-risk patients (NIRS + CSF drainage)Low-risk patients (NIRS alone)

A lumbar cerebrospinal fluid drainage catheter is inserted (typically at L3-L4) and managed to maintain cerebrospinal fluid pressure below 10 mmHg, with the aim of optimizing spinal cord perfusion pressure (SCPP ≥75 mmHg) during and after aortic surgery.

Also known as: CSF DRAINAGE, LUMBAR DRANAIGE, CEREBROSPINAL FLUID DRANAIGE, SPINAL DRANAIGE
High-risk patients (NIRS + CSF drainage)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients undergoing elective thoracic and thoracoabdominal aortic repair procedures, including open, endovascular (TEVAR/FEVAR), and hybrid interventions, at Monaldi Hospital, A.O.R.N. Ospedali dei Colli, Naples, Italy. Participants will be recruited consecutively from the vascular and cardiovascular surgical units where intraoperative spinal cord monitoring is routinely performed.

You may qualify if:

  • Adult patients aged 18 years or older Patients scheduled for elective thoracic or thoracoabdominal aortic repair, including open, endovascular (TEVAR/FEVAR), or hybrid procedures Patients undergoing intraoperative paraspinal near-infrared spectroscopy (NIRS) monitoring Written informed consent obtained before enrollment

You may not qualify if:

  • Age under 18 years Emergency surgical procedures Pregnancy Pre-existing paraplegia or severe neurological impairment Skin lesions or conditions preventing correct placement of NIRS sensors Refusal or inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AORN Ospedali dei Colli - Monaldi Hospital

Naples, Italy, 80100, Italy

RECRUITING

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Spectroscopy, Near-Infrared

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Salvatore Notaro

    AORN Ospedali dei Colli - Monaldi Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Anesthesiologist and Intensive Care Specialist

Study Record Dates

First Submitted

April 14, 2026

First Posted

April 21, 2026

Study Start

August 23, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

March 30, 2027

Last Updated

April 21, 2026

Record last verified: 2026-03

Locations